Rheumatology

Hepatitis B

Questions discussed in this category

How would you approach initiating belimumab in a patient with serologic evidence of prior hepatitis B infection?

Such as patients with negative Hepatitis B surface antigen and negative viral load but with positive hepatitis b core antibody.

1 Answer available

How do you manage patients who are Hepatitis B core antibody positive/surface antigen negative and starting a biologic DMARD (other than rituximab)?

1 Answer available

Should patients be screened for hepatitis B/C prior to starting a conventional synthetic DMARD such as methotrexate?

1 Answer available

Papers discussed in this category

Semin. Arthritis Rheum., 2020 Mar 19

RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs.

Arthritis Rheumatol, 2016 Jan

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Related Topics in Rheumatology